Drug Pipeline

Ubamatamab Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
4
Recruiting
3
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-10 NCT07637851 Safety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian Cancer Phase 1/2 Not Yet Recruiting
Active Studies by Phase
Phase 2
3
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06787612 Investigation of Ubamatamab Combination Therapy in Adult Participants With… Ovarian Cancer Recruiting
NCT07154290 A Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With… Advanced/Metastatic Non-Small Cell Lung Cancer Recruiting
NCT06444880 Phase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing… SMARCB1-Deficient Malignancies Recruiting
Phase 1/2
NCT03564340 Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in… Recurrent Ovarian Cancer Recruiting
NCT07637851 Safety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian Cancer Ovarian Cancer Not Yet Recruiting
Sponsors Running Ubamatamab Trials
Regeneron Pharmaceuticals (3) M.D. Anderson Cancer Center (1) ARCAGY/ GINECO GROUP (1)
Disease Areas
Ovarian Cancer (3) Endometrial Cancer (1) Sarcoma (1) Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1)
Get alerts when Ubamatamab trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free